What is Medline, Inc. 's debt issuance costs, net?

Medline, Inc. (MDLN) reported debt issuance costs, net of $184.00M in Q1 2026.

What does debt issuance costs, net mean?

The unamortized costs associated with issuing debt, such as bank fees and legal expenses.

Discontinued — last reported Q4 '21

Medline, Inc. Debt Issuance Costs, Net decreased by 5.6% to $184.00M in Q1 2026 compared to the prior quarter.

StatementBalance Sheet Statement

SectionOther

CategoryLeverage

SignalContext dependent

VolatilityStable

First reportedQ4 2017

Last reportedQ4 2021

Higher balances indicate recent significant debt issuance activity; the amortization schedule impacts interest expense.

Costs incurred in connection with the issuance of debt, such as underwriting fees and legal expenses, which are capitali...

Standard for all capital-intensive firms; proportional to the total amount of outstanding debt.

Metric ID: other_deferred_finance_costs_net

2 periods

	Q4 '25	Q1 '26
Value	$195.00M	$184.00M
QoQ Change	—	-5.6%

Range$184.00M – $195.00M

What is Medline, Inc. 's debt issuance costs, net?: Medline, Inc. (MDLN) reported debt issuance costs, net of $184.00M in Q1 2026.
What does debt issuance costs, net mean?: The unamortized costs associated with issuing debt, such as bank fees and legal expenses.